Temitope Ekwo
Obstetrics & Gynecology · Houston, TXNPI 1295022507
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,393 of the $4,160 with a category attached, or 81.6%. It is spread thinly across 36 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,474 and has fallen 67.3% since, to $482 in 2025.
Across 160 payments — averaging $26.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$750
- AbbVie$569
- Hologic Sales And Service, LLC$233
- Evofem Biosciences, Inc.$217
- Mayne Pharma Commercial LLC$195
- Astellas Pharma US Inc$184
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,39382%
- Education$76618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $750 |
| AbbVie | 29 | $569 |
| Hologic Sales And Service, LLC | 8 | $233 |
| Evofem Biosciences, Inc. | 11 | $217 |
| Mayne Pharma Commercial LLC | 9 | $195 |
| Astellas Pharma US Inc | 7 | $184 |
| Sage Therapeutics, LLC | 8 | $178 |
| Myovant Sciences Inc. | 8 | $177 |
| Pfizer | 9 | $152 |
| Sumitomo Pharma America, Inc. | 7 | $151 |
| Exeltis, USA Inc. | 7 | $143 |
| Organon | 6 | $120 |
| Avion Pharmaceuticals | 8 | $109 |
| Shield Therapeutics Inc | 4 | $107 |
| Bayer | 4 | $99 |
| Lupin Inc. | 6 | $99 |
| Exact Sciences | 4 | $85 |
| Medtronic | 1 | $69 |
| Johnson & Johnson | 1 | $66 |
| Agile Therapeutics, Inc. | 3 | $54 |
| Apollo Endosurgery US Inc | 1 | $43 |
| Aspira Women's Health Inc | 2 | $41 |
| Dysis Medical, Inc. | 1 | $35 |
| Merck | 2 | $34 |
| Coopersurgical, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Scynexis, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Bolder Surgical, LLC | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$750
How this compares
$4,160 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $885 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.